No retraction, correction or concern found when last checked on Oct 23, 2026.

Assessment of Inflammatory Hematological Ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in Acute Myocardial Infarction and Particularities in Young Patients

Bogdan-Sorin Tudurachi, Larisa Anghel, Andreea Tudurachi and 2 more

International Journal of Molecular Sciences · 2023 · Review · CC BY

Abstract

Cardiovascular disease, particularly coronary artery disease (CAD), remains a predominant cause of mortality globally. Factors such as atherosclerosis and inflammation play significant roles in the pathogenesis of CAD. The nexus between inflammation and CAD is underscored by the role of immune cells, such as neutrophils, lymphocytes, monocytes, and macrophages. These cells orchestrate the inflammatory process, a core component in the initiation and progression of atherosclerosis. The activation of these pathways and the subsequent lipid, fibrous element, and calcification accumulation can result in vessel narrowing. Hematological parameters derived from routine blood tests offer insights into the underlying inflammatory state. Recent studies have highlighted the potential of inflammatory hematological ratios, such as the neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, monocyte/lymphocyte ratio and lymphocyte/monocyte ratio. These parameters are not only accessible and cost-effective but also mirror the degree of systemic inflammation. Several studies have indicated a correlation between these markers and the severity, prognosis, and presence of CAD. Despite the burgeoning interest in the relationship between inflammatory markers and CAD, there remains a paucity of data exploring these parameters in young patients with acute myocardial infarction. Such data could offer valuable insights into the unique pathophysiology of early-onset CAD and improve risk assessment and predictive strategies.

References 82

1.
Chen C., Cong B.L., Wang M., Abdullah M., Wang X.L., Zhang Y.H., Xu S.J., Cui L. Neutrophil to lymphocyte ratio as a predictor of myocardial damage and cardiac dysfunction in acute coronary syndrome patients. Integr. Med. Res. 2018;7:192-199.
Not in our library10.1016/j.imr.2018.02.006
2.
Caimi G., Lo Presti R., Canino B., Ferrera E., Hopps E. Behaviour of the neutrophil to lymphocyte ratio in young subjects with acute myocardial infarction. Clin. Hemorheol. Microcirc. 2016;62:239-247.
Not in our library10.3233/ch-151968
3.
Hartaigh B., Bosch J.A., Thomas G.N., Lord J.M., Pilz S., Loerbroks A., Kleber M.E., Grammer T.B., Fischer J.E., Boehm B.O., et al. Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Atherosclerosis. 2012;224:161-169.
Not in our library10.1016/j.atherosclerosis.2012.04.012
4.
Nunez J., Nunez E., Bodi V., Sanchis J., Minana G., Mainar L., Santas E., Merlos P., Rumiz E., Darmofal H., et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am. J. Cardiol. 2008;101:747-752.
Not in our library10.1016/j.amjcard.2007.11.004
5.
Lee G.K., Lee L.C., Chong E., Lee C.H., Teo S.G., Chia B.L., Poh K.K. The long-term predictive value of the neutrophil-to-lymphocyte ratio in Type 2 diabetic patients presenting with acute myocardial infarction. QJM. 2012;105:1075-1082.
Not in our library10.1093/qjmed/hcs123
6.
Caimi G., Montana M., Andolina G., Hopps E., Lo Presti R. Plasma Viscosity and NLR in Young Subjects with Myocardial Infarction: Evaluation at the Initial Stage and at 3 and 12 Months. Clin. Med. Insights Cardiol. 2019;13:1179546819849428.
Not in our library10.1177/1179546819849428
7.
Performance of neutrophil to lymphocyte ratio for the prediction of long-term morbidity and mortality in coronary slow flow phenomenon patients presented with non-ST segment elevation acute coronary syndrome · 2021
Not checked
8.
Sasmita B.R., Zhu Y., Gan H., Hu X., Xue Y., Xiang Z., Huang B., Luo S. Prognostic value of neutrophil-lymphocyte ratio in cardiogenic shock complicating acute myocardial infarction: A cohort study. Int. J. Clin. Pract. 2021;75:e14655.
Not in our library10.1111/ijcp.14655
9.
Sia C.H., Leow A.S., Tan B.Y., Low C.J., Kaur R., Yeo T.C., Chan M.Y., Tay E.L., Yeo L.L., Yap E.S., et al. The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict left ventricular thrombus resolution in acute myocardial infarction without percutaneous coronary intervention. Thromb. Res. 2020;194:16-20.
Not in our library10.1016/j.thromres.2020.06.003
10.
Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis · 2018
No notice
11.
Dong G., Huang A., Liu L. Platelet-to-lymphocyte ratio and prognosis in STEMI: A meta-analysis. Eur. J. Clin. Investig. 2021;51:e13386.
Not in our library10.1111/eci.13386
12.
Chen B., Yuan L., Chen X., Li J., Tao J., Li W., Zheng R. Correlations and Prognostic Roles of the Nutritional Status and Neutrophil-to-lymphocyte Ratio in Elderly Patients with Acute Myocardial Infarction Undergoing Primary Coronary Intervention. Int. Heart J. 2020;61:1114-1120.
Not in our library10.1536/ihj.20-138
13.
Ji Z., Liu G., Guo J., Zhang R., Su Y., Carvalho A., Qu Y., Zuo W., Yao Y., Lin J., et al. The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients. Front. Cardiovasc. Med. 2021;8:706852.
Not in our library10.3389/fcvm.2021.706852
14.
Chen Y., Chen S., Han Y., Xu Q., Zhao X. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Important Indicators for Predicting in-Hospital Death in Elderly AMI Patients. J. Inflamm. Res. 2023;16:2051-2061.
Not in our library10.2147/jir.s411086
15.
Li L., Ma Y., Geng X.B., Tan Z., Wang J.H., Cui C., Wang H.L., Shang X.M. Platelet-to-lymphocyte ratio relates to poor prognosis in elderly patients with acute myocardial infarction. Aging Clin. Exp. Res. 2021;33:619-624.
Not in our library10.1007/s40520-020-01555-7
16.
Lionte C., Sorodoc V., Haliga R.E., Bologa C., Ceasovschih A., Petris O.R., Coman A.E., Stoica A., Sirbu O., Puha G., et al. Inflammatory and cardiac biomarkers in relation with post-acute COVID-19 and mortality: What we know after successive pandemic waves. Diagnostics. 2022;12:1373.
Not in our library10.3390/diagnostics12061373
17.
Gazi E., Bayram B., Gazi S., Temiz A., Kirilmaz B., Altun B., Barutcu A. Prognostic Value of the Neutrophil-Lymphocyte Ratio in Patients with ST-Elevated Acute Myocardial Infarction. Clin. Appl. Thromb. Hemost. 2015;21:155-159.
Not in our library10.1177/1076029613492011
18.
Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients · 2022
No notice
19.
Serrano C.V., de Mattos F.R., Pitta F.G., Nomura C.H., de Lemos J., Ramires J.A.F., Kalil-Filho R. Association between Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios and Coronary Artery Calcification Score among Asymptomatic Patients: Data from a Cross-Sectional Study. Mediat. Inflamm. 2019;2019:6513847.
Not in our library10.1155/2019/6513847
20.
Verdoia M., Nardin M., Gioscia R., Negro F., Marcolongo M., Suryapranata H., Kedhi E., De Luca G., Novara Atherosclerosis Study Group (NAS). Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor. Vascul. Pharmacol. 2020;132:106765.
Not in our library10.1016/j.vph.2020.106765
21.
Hong D., Choi K.H., Song Y.B., Lee J.M., Park T.K., Yang J.H., Hahn J.Y., Choi J.H., Choi S.H., Kim S.M., et al. Prognostic implications of post-percutaneous coronary intervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarction. Sci. Rep. 2019;9:9646.
Not in our library10.1038/s41598-019-46117-8
22.
Tahto E., Jadric R., Pojskic L., Kicic E. Neutrophil-to-lymphocyte Ratio and Its Relation with Markers of Inflammation and Myocardial Necrosis in Patients with Acute Coronary Syndrome. Med. Arch. 2017;71:312-315.
Not in our library10.5455/medarh.2017.71.312-315
23.
Sheng J., Liu N., He F., Cheng C., Shen S., Sun Y. Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome. Clinics. 2021;76:e2580.
Not in our library10.6061/clinics/2021/e2580
24.
Xu N., Tang X.F., Yao Y., Zhao X., Chen J., Gao Z., Yang Y., Gao R.L., Xu B., Yuan J.Q. Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction. Catheter. Cardiovasc. Interv. 2018;91:551-557.
Not in our library10.1002/ccd.27495
25.
Cho K.H., Shin M.H., Kim M.C., Sim D.S., Hong Y.J., Kim J.H., Ahn Y., Chae S.C., Seong I.W., Park J.S., et al. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio Combined with Anemia in Patients with ST-Segment Elevation Myocardial Infarction: A Nationwide Prospective Cohort Study. J. Lipid Atheroscler. 2022;11:147-160.
Not in our library10.12997/jla.2022.11.2.147
26.
Jun S.J., Jeong M.H., Cho K.H., Ahn Y., Kim J.H., Cho J.G., Chae S.C., Kim Y.J., Seong I.W., Chae J.K., et al. Early Valuable Risk Stratification with Hemoglobin Level and Neutrophil to Lymphocyte Ratio in Patients with Non-ST-Elevation Myocardial Infarction Having an Early Invasive Strategy. J. Lipid Atheroscler. 2018;7:50-61.
Not in our library10.12997/jla.2018.7.1.50
27.
Association of neutrophil to lymphocyte ratio (NLR) with angiographic SYNTAX score in patients with non-ST-Segment elevation acute coronary syndrome (NSTE-ACS) · 2021
Not checked
28.
Zuin M., Rigatelli G., Picariello C., dell’Avvocata F., Marcantoni L., Pastore G., Carraro M., Nanjundappa A., Faggian G., Roncon L. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience. Cardiovasc. Revasc. Med. 2017;18:565-571.
Not in our library10.1016/j.carrev.2017.05.007
29.
Del Turco S., Basta G., De Caterina A.R., Sbrana S., Paradossi U., Taddei A., Trianni G., Ravani M., Palmieri C., Berti S., et al. Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality. Int. J. Cardiol. 2019;290:34-39.
Not in our library10.1016/j.ijcard.2019.05.002
30.
Budzianowski J., Pieszko K., Burchardt P., Rzezniczak J., Hiczkiewicz J. The Role of Hematological Indices in Patients with Acute Coronary Syndrome. Dis. Markers. 2017;2017:3041565.
Not in our library10.1155/2017/3041565
31.
Willim H.A., Harianto J.C., Cipta H. Platelet-to-Lymphocyte Ratio at Admission as a Predictor of In-Hospital and Long-Term Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Cardiol. Res. 2021;12:109-116.
Not in our library10.14740/cr1219
32.
Luke K., Purwanto B., Herawati L., Al-Farabi M.J., Oktaviono Y.H. Predictive Value of Hematologic Indices in the Diagnosis of Acute Coronary Syndrome. Open Access Maced. J. Med. Sci. 2019;7:2428-2433.
Not in our library10.3889/oamjms.2019.666
33.
Wang H., Li L., Ma Y. Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study. Clin. Cardiol. 2023;46:632-638.
Not in our library10.1002/clc.24002
34.
Prognostic value of peripheral blood inflammatory cell subsets in patients with acute coronary syndrome undergoing percutaneous coronary intervention · 2021
Not checked
35.
Liu J., Ao W., Zhou J., Luo P., Wang Q., Xiang D. The correlation between PLR-NLR and prognosis in acute myocardial infarction. Am. J. Transl. Res. 2021;13:4892-4899.
Not in our library
36.
Chen Y., Chen S., Han Y., Xu Q., Zheng M., Zhao X. A combined index constructed based on NLR and PLR is associated with in-hospital mortality risk in patients with acute myocardial infarction. Am. J. Transl. Res. 2023;15:4118-4128.
Not in our library
37.
Oylumlu M., Oylumlu M., Arslan B., Polat N., Ozbek M., Demir M., Yildiz A., Toprak N. Platelet-to-lymphocyte ratio is a predictor of long-term mortality in patients with acute coronary syndrome. Postep. Kardiol. Interwencyjnej. 2020;16:170-176.
Not in our library10.5114/aic.2020.95859
38.
Meng Z., Yang J., Wu J., Zheng X., Zhao Y., He Y. Association between the platelet-lymphocyte ratio and short-term mortality in patients with non-ST-segment elevation myocardial infarction. Clin. Cardiol. 2021;44:994-1001.
Not in our library10.1002/clc.23648
39.
Karadeniz F.O., Karadeniz Y., Altuntas E. Systemic immune-inflammation index, and neutrophilto-lymphocyte and platelet-to-lymphocyte ratios can predict clinical outcomes in patients with acute coronary syndrome. Cardiovasc. J. Afr. 2023;34:1-7.
Not in our library10.5830/cvja-2023-011
40.
Maimaiti A., Li Y., Wang Y.T., Yang X., Li X.M., Yang Y.N., Ma Y.T. Association of platelet-to-lymphocyte count ratio with myocardial reperfusion and major adverse events in patients with acute myocardial infarction: A two-centre retrospective cohort study. BMJ Open. 2019;9:e025628.
Not in our library10.1136/bmjopen-2018-025628
41.
Badran H.M., Fatah A.A., Soltan G. Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention. J. Clin. Transl. Res. 2020;6:20-26.
Not in our library10.18053/jctres.06.202001.004
42.
Senoz O., Emren S.V., Ersecgin A., Yapan Emren Z., Gul I. Platelet-Lymphocyte ratio is a predictor for the development of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction after thrombus aspiration. J. Clin. Lab. Anal. 2021;35:e23795.
Not in our library10.1002/jcla.23795
43.
Dolu A.K., Karayigit O., Ozkan C., Celik M.C., Kalcik M. Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment elevation myocardial infarction. Acta Cardiol. 2023;78:72-79.
Not in our library10.1080/00015385.2022.2035082
44.
Cankurt T., Celik I.E., Ozturk S., Maden O. Inflammatory Conditions in Acute Coronary Syndrome Patients Treated with Percutaneous Coronary Intervention of Saphenous Vein Graft. Int. J. Angiol. 2020;29:237-244.
Not in our library10.1055/s-0040-1714751
45.
Seaoud E., Mohamed A., Elkot M.A. The Role of the Platelet/Lymphocyte Ratio and Neutrophil/Lymphocyte Ratio in Predicting High-Risk Heart Score in Patients Admitted with Non-ST Elevation Acute Coronary Syndrome. Pulse. 2020;8:66-74.
Not in our library10.1159/000508592
46.
Li X.T., Fang H., Li D., Xu F.Q., Yang B., Zhang R., An Y. Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction. Chin. Med. J. 2020;133:415-423.
Not in our library10.1097/cm9.0000000000000650
47.
Li W., Liu Q., Tang Y. Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome: A meta-analysis. Sci. Rep. 2017;7:40426.
Not in our library10.1038/srep40426
48.
Zhang Q., Si D., Zhang Z., Wang C., Zheng H., Li S., Huang S., Zhang W. Value of the platelet-to-lymphocyte ratio in the prediction of left ventricular thrombus in anterior ST-elevation myocardial infarction with left ventricular dysfunction. BMC Cardiovasc. Disord. 2020;20:428.
Not in our library10.1186/s12872-020-01712-w
49.
Wen H., Yu H. Correlation analysis of carotid plaque in young patients with newly diagnosed type 2 diabetes and platelet-to-lymphocyte ratio and neutrophil-lymphocyte ratio. Vascular. 2023;31:90-97.
Not in our library10.1177/17085381211052362
50.
Trakarnwijitr I., Li B., Adams H., Layland J., Garlick J., Wilson A. Age modulates the relationship between platelet-to-lymphocyte ratio and coronary artery disease. Int. J. Cardiol. 2017;248:349-354.
Not in our library10.1016/j.ijcard.2017.06.127
51.
Kazem N., Hofer F., Koller L., Hammer A., Hofbauer T.M., Hengstenberg C., Niessner A., Sulzgruber P. The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndrome. Eur. Heart J. Open. 2022;2:oeab031.
Not in our library10.1093/ehjopen/oeab031
52.
Dai K., Li Z., Luo Y., Xiong Q., Xiong Y., Song Z., Xiong W. The Predictive Value of the Monocyte-to-Lymphocyte Ratio and Monocyte-to-Haematocrit Ratio for Cardiac Rupture Patients with Acute Myocardial Infarction: A Propensity Score Matching Analysis. Risk Manag. Healthc. Policy. 2022;15:37-44.
Not in our library10.2147/rmhp.s348894
53.
Fan Z., Li Y., Ji H., Jian X. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: A retrospective cohort study. BMJ Open. 2018;8:e023459.
Not in our library10.1136/bmjopen-2018-023459
54.
Yan X.N., Jin J.L., Zhang M., Hong L.F., Guo Y.L., Wu N.Q., Zhu C.G., Dong Q., Li J.J. Differential leukocyte counts and cardiovascular mortality in very old patients with acute myocardial infarction: A Chinese cohort study. BMC Cardiovasc. Disord. 2020;20:465.
Not in our library10.1186/s12872-020-01743-3
55.
Dai K., Li Z., Luo Y., Xiong Q., Xiong Y., Song Z., Xiong W. Neutrophil percentage-to-albumin ratio and monocyte-to-lymphocyte ratio as predictors of free-wall rupture in patients with acute myocardial infarction. J. Clin. Lab. Anal. 2022;36:e24136.
Not in our library10.1002/jcla.24136
56.
Zhang T.Y., Zhao Q., Liu Z.S., Zhang C.Y., Yang J., Meng K. Relationship between monocyte/lymphocyte ratio and non-culprit plaque vulnerability in patients with acute coronary syndrome: An optical coherence tomography study. Medicine. 2020;99:e21562.
Not in our library10.1097/md.0000000000021562
57.
The Admission (Neutrophil+Monocyte)/Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Patients With Acute Myocardial Infarction · 2022
Not checked
58.
Ceasovschih A., Sorodoc V., Onofrei V., Tesloianu D., Tuchilus C., Anisie E., Petris A., Statescu C. Biomarker utility for peripheral artery disease diagnosis in real clinical practice: A prospective study. Diagnostics. 2020;10:E723.
Not in our library10.3390/diagnostics10090723
59.
Oylumlu M., Oylumlu M., Arik B., Demir M., Ozbek M., Arslan B., Acun B., Polat N., Akil M.A., Bilik M.Z. Monocyte to high-density lipoprotein cholesterol and lymphocyte to monocyte ratios are predictors of in-hospital and long-term mortality in patients with acute coronary syndrome. Int. J. Clin. Pract. 2021;75:e13973.
Not in our library10.1111/ijcp.13973
60.
The prognostic value of admission lymphocyte-to-monocyte ratio in critically ill patients with acute myocardial infarction · 2022
Not checked
61.
Cao J., Li R., He T., Zhang L., Liu H., Wu X. Role of combined use of mean platelet volume-to-lymphocyte ratio and monocyte to high-density lipoprotein cholesterol ratio in predicting patients with acute myocardial infarction. J. Cardiothorac. Surg. 2023;18:172.
Not in our library10.1186/s13019-023-02268-4
62.
Ganjali S., Gotto A.M., Ruscica M., Atkin S.L., Butler A.E., Banach M., Sahebkar A. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J. Cell Physiol. 2018;233:9237-9246.
Not in our library10.1002/jcp.27028
63.
Hafiane A., Genest J. High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk. BBA Clin. 2015;3:175-188.
Not in our library10.1016/j.bbacli.2015.01.005
64.
Sun M., Zhao D., Zhang Y., Zhai Y., Ye M., Wang X., Zheng L., Wang L. Prognostic Utility of Monocyte to High-Density Lipoprotein Ratio in Patients with Acute Coronary Syndrome: A Meta-Analysis. Am. J. Med. Sci. 2020;359:281-286.
Not in our library10.1016/j.amjms.2020.01.018
65.
Villanueva D.L.E., Tiongson M.D., Ramos J.D., Llanes E.J. Monocyte to High-Density Lipoprotein Ratio (MHR) as a predictor of mortality and Major Adverse Cardiovascular Events (MACE) among ST Elevation Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention: A meta-analysis. Lipids Health Dis. 2020;19:55.
Not in our library10.1186/s12944-020-01242-6
66.
Cetin M.S., Ozcan Cetin E.H., Kalender E., Aydin S., Topaloglu S., Kisacik H.L., Temizhan A. Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. Heart Lung Circ. 2016;25:1077-1086.
Not in our library10.1016/j.hlc.2016.02.023
67.
Zhang D.P., Baituola G., Wu T.T., Chen Y., Hou X.G., Yang Y., Pan Y., Ma X., Zheng Y.Y. An elevated monocyte-to-high-density lipoprotein-cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI. Biosci. Rep. 2020;40:BSR20201108.
Not in our library10.1042/bsr20201108
68.
Sercelik A., Besnili A.F. Increased monocyte to high-density lipoprotein cholesterol ratio is associated with TIMI risk score in patients with ST-segment elevation myocardial infarction. Rev. Port. Cardiol. (Engl. Ed.). 2018;37:217-223.
Not in our library10.1016/j.repc.2017.06.021
69.
Karim K., Aulia M.S., Pradisa I.S., Huda M.F., Setyasari A., Yosephina S., Ubaidillah N. Monocyte to high-density lipoprotein cholesterol ratio as highly predictive marker in patients with acute coronary syndrome. Future Cardiol. 2023;19:261-270.
Not in our library10.2217/fca-2023-0001
70.
Admission Monocyte/HDL Ratio Predicts Adverse Cardiac Remodeling After St-Elevation Myocardial Infarction · 2022
Not checked
71.
Kalyoncuoglu M., Biter H.I., Ozturk S., Belen E., Can M.M. Predictive accuracy of lymphocyte-to-monocyte ratio and monocyte-to-high-density-lipoprotein-cholesterol ratio in determining the slow flow/no-reflow phenomenon in patients with non-ST-elevated myocardial infarction. Coron. Artery Dis. 2020;31:518-526.
Not in our library10.1097/mca.0000000000000848
72.
Kojima Y., Weissman I.L., Leeper N.J. The Role of Efferocytosis in Atherosclerosis. Circulation. 2017;135:476-489.
Not in our library10.1161/circulationaha.116.025684
73.
Brophy M.L., Dong Y., Wu H., Rahman H.N., Song K., Chen H. Eating the Dead to Keep Atherosclerosis at Bay. Front. Cardiovasc. Med. 2017;4:2.
Not in our library10.3389/fcvm.2017.00002
74.
Immune Mechanisms of Plaque Instability · 2022
Not checked
75.
Mohmmad-Rezaei M., Arefnezhad R., Ahmadi R., Abdollahpour-Alitappeh M., Mirzaei Y., Arjmand M.-H., Ferns G.A., Bashash D., Bagheri N. An overview of the innate and adaptive immune system in atherosclerosis. IUBMB Life. 2021;73:64-91.
Not in our library10.1002/iub.2425
76.
Chowdhury A.S., Tamanna S., Kar K. Role of macrophages in atherosclerosis. Asian J. Med. Biol. Res. 2020;6:366-374.
Not in our library10.3329/ajmbr.v6i3.49784
77.
Tahir N., Zahra F. Neutrophilia. 27 April 2023. StatPearls [Internet]. 2023.
Not in our library
78.
Agbuduwe C., Basu S. Haematological manifestations of COVID-19: From cytopenia to coagulopathy. Eur. J. Haematol. 2020;105:540-546.
Not in our library10.1111/ejh.13491
79.
Moir S., Chun T.W., Fauci A.S. Pathogenic mechanisms of HIV disease. Annu. Rev. Pathol. 2011;6:223-248.
Not in our library10.1146/annurev-pathol-011110-130254
80.
Puck J.M. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia. Immunol. Rev. 2019;287:241-252.
Not in our library10.1111/imr.12729
81.
Mathur A., Samaranayake S., Storrar N.P., Vickers M.A. Investigating thrombocytosis. BMJ. 2019;366:l4183.
Not in our library10.1136/bmj.l4183
82.
Mangaonkar A.A., Tande A.J., Bekele D.I. Differential Diagnosis and Workup of Monocytosis: A Systematic Approach to a Common Hematologic Finding. Curr. Hematol. Malig. Rep. 2021;16:267-275.
Not in our library10.1007/s11899-021-00618-4

Cited by papers we hold 1

The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension · 2024
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.